ResearcherSecond Military Medical UniversityNo recent work listed
Xiangui Hu
Matched on OpenAlex author ID A5102118517. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 41
2011: 3 papers · 2012: none · 2013: none · 2014: 3 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 12
- Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. Co-author DOI 10.1016/j.ijsu.2022.106786↗
- MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer. Co-author DOI 10.21037/atm-21-6556↗
- Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysis. Co-author DOI 10.21037/cco-20-6↗
- Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways. Co-author DOI 10.3892/ijo.2018.4574↗
- Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway. Last author DOI 10.1016/j.canlet.2015.09.019↗
- Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation. Last author DOI 10.1186/s12943-015-0447-5↗
- Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Co-author DOI 10.1002/ijc.28471↗
- miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. Last author DOI 10.1007/s12013-013-9805-3↗
- Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer. Last author DOI 10.1007/s13277-014-2564-y↗
- MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2011.02.086↗
- MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. Co-author DOI 10.1016/j.febslet.2010.11.039↗
- Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Co-author DOI 10.1093/carcin/bgr105↗
Closest collaborators
The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chenghao Shao · 7 shared papers, 2011–2018 · strength 0.30
- Paper Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK s… DOI 10.3892/ijo.2018.4574↗
- Paper Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy… DOI 10.1186/s12943-015-0447-5↗
- Paper miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. DOI 10.1007/s12013-013-9805-3↗
- Gang Jin · 5 shared papers, 2014–2020 · strength 0.28
- Paper Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dua… DOI 10.21037/cco-20-6↗
- Paper Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signali… DOI 10.1016/j.canlet.2015.09.019↗
- Paper Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy… DOI 10.1186/s12943-015-0447-5↗
- Shiwei Guo · 3 shared papers, 2014–2022 · strength 0.25
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Paper Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dua… DOI 10.21037/cco-20-6↗
- Paper Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. DOI 10.1002/ijc.28471↗
- Gang Li · 2 shared papers, 2020–2022 · strength 0.21
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Paper Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dua… DOI 10.21037/cco-20-6↗
- Tianlin He · 2 shared papers, 2020–2022 · strength 0.21
- Paper Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospectiv… DOI 10.1016/j.ijsu.2022.106786↗
- Paper Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dua… DOI 10.21037/cco-20-6↗
- Liu Ouyang · 2 shared papers, 2014–2021 · strength 0.18
- Paper MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by … DOI 10.21037/atm-21-6556↗
- Paper miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. DOI 10.1007/s12013-013-9805-3↗
- Jun Hao · 5 shared papers, 2011–2014 · strength 0.18
- Paper miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. DOI 10.1007/s12013-013-9805-3↗
- Paper Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer. DOI 10.1007/s13277-014-2564-y↗
- Paper MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. DOI 10.1016/j.febslet.2010.11.039↗
- Gang Jin · 1 shared paper, 2021 · strength 0.14
- Suizhi Gao · 1 shared paper, 2022 · strength 0.13
- Kailian Zheng · 1 shared paper, 2022 · strength 0.13
- Shuo Shen · 1 shared paper, 2022 · strength 0.13
- Bo Li · 1 shared paper, 2022 · strength 0.13
- Guoxiao Zhang · 1 shared paper, 2022 · strength 0.13
- Gang Jin · 1 shared paper, 2022 · strength 0.13
- Xiaoyi Yin · 1 shared paper, 2022 · strength 0.13
- Xiaohan Shi · 1 shared paper, 2022 · strength 0.13
- An‐An Liu · 2 shared papers, 2014–2018 · strength 0.12
- Paper Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK s… DOI 10.3892/ijo.2018.4574↗
- Paper miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. DOI 10.1007/s12013-013-9805-3↗
- Anan Liu · 2 shared papers, 2014–2015 · strength 0.09
- Bin Song · 2 shared papers, 2014–2015 · strength 0.09
- Paper Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy… DOI 10.1186/s12943-015-0447-5↗
- Paper miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. DOI 10.1007/s12013-013-9805-3↗
- Shuyu Zhang · 3 shared papers, 2011 · strength 0.09
- Paper MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. DOI 10.1016/j.febslet.2010.11.039↗
- Paper MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. DOI 10.1016/j.bbrc.2011.02.086↗
- Paper Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. DOI 10.1093/carcin/bgr105↗
- Ding Ding · 1 shared paper, 2020 · strength 0.08
- Michele Maiko Gage · 1 shared paper, 2020 · strength 0.08
- Jin Peng He · 1 shared paper, 2020 · strength 0.08
- Jonathan G. Sham · 1 shared paper, 2020 · strength 0.08
- Richard Andrew Burkhart · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.